| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/04/2003 | EP1315493A1 2-3-disubstituted quinuclidines as modulators of monoamine transporters and therapeutic and diagnostic methods based thereon |
| 06/04/2003 | EP1315492A2 A method for treating allergies using substituted pyrazoles |
| 06/04/2003 | EP1315491A2 Method for treating allergies using substituted pyrazoles |
| 06/04/2003 | EP1315490A2 A method for treating allergies using substituted pyrazoles |
| 06/04/2003 | EP1315488A2 Pharmaceutical compositions containing aminothiazole derivatives for the treatment of colonic motor dysfunctions |
| 06/04/2003 | EP1315487A2 Flavoring systems for pharmaceutical compositions and methods of making such compositions |
| 06/04/2003 | EP1315486A2 Antitumor combination comprising an aromatase inhibitor and an egfr antagonist or inhibitor |
| 06/04/2003 | EP1315485A1 Cathartic composition |
| 06/04/2003 | EP1315484A1 Taxane-based compositions and methods of use |
| 06/04/2003 | EP1315483A2 Combined estrogen blockade of the breast with exemestane and raloxifene |
| 06/04/2003 | EP1315482A2 Water-dispersible encapsulated sterols |
| 06/04/2003 | EP1315481A1 Medicament for treating intestinal diseases |
| 06/04/2003 | EP1315474A2 Clear antiperspirants and deodorants made with siloxane-based polyamides |
| 06/04/2003 | EP1315473A2 Use of ectoine or ectoine derivatives for oral care |
| 06/04/2003 | EP1282609A4 Piperazinedione compounds |
| 06/04/2003 | EP1252150B1 Heterocyclic derivatives, preparation method and pharmaceutical compositions containing same |
| 06/04/2003 | EP1232156B1 [1,2,3]-TRIAZOLO[4,5-d]PYRIMIDINE DERIVATIVES AS ANTI-THROMBOTIC AGENTS |
| 06/04/2003 | EP1226120B1 Benz[f]indoles for use in the treatment of 5ht receptor related disorders |
| 06/04/2003 | EP1216046B1 Novel combination of loteprednol and antihistamines |
| 06/04/2003 | EP1207857B1 Ciprofloxacin containing pharmaceutical composition and process for the preparation thereof |
| 06/04/2003 | EP1206248B1 Controlled-release sedative-hypnotic compositions and methods related thereto |
| 06/04/2003 | EP1200099B1 Synergistic composition comprising daunorubicin derivatives and antimetabolite compounds |
| 06/04/2003 | EP1200088B1 Paracetamol and drotaverine containing composition |
| 06/04/2003 | EP1198224B1 Formulations of steroid solutions for inhalatory administration |
| 06/04/2003 | EP1171108B1 Combination preparation for treating malaria |
| 06/04/2003 | EP1165565B1 Optically pure camptothecin analogues |
| 06/04/2003 | EP1165543B1 PROCESS FOR PREPARING S-(R*,S*)] -$g(b) - 1- 1-OXO-3- (4-PIPERIDINYL) PROPYL] -3-PIPERIDINYL] CARBONYL] AMINO] -3- PYRIDINEPROPANOIC ACID AND DERIVATIVES |
| 06/04/2003 | EP1159061A4 Chemical method for making pyrithione particle dispersions |
| 06/04/2003 | EP1156790B1 Combinations of formoterol and mometasone furoate |
| 06/04/2003 | EP1155014B1 New benzimidazole compounds for use as active therapeutic substances, process for the preparation of these compoudns and pharmaceutical compositions comprising them |
| 06/04/2003 | EP1143928B1 Milling process for the production of finely milled medicinal substances |
| 06/04/2003 | EP1140945B1 Fused 1,2,4-thiadiazine derivatives, their preparation and use |
| 06/04/2003 | EP1140186B1 Combinations of cholesteryl ester transfer protein inhibitors and fibric acid derivatives for cardiovascular indications |
| 06/04/2003 | EP1140185B1 Combinations of cholesteryl ester transfer protein inhibitors and bile acid sequestering agents for cardiovascular indications |
| 06/04/2003 | EP1140184B1 Combinations of cholesteryl ester transfer protein inhibitors and nicotinic acid derivatives for cardiovascular indications |
| 06/04/2003 | EP1126782A4 Method for improved imaging and photodynamic therapy |
| 06/04/2003 | EP1121121B1 Methods for inhibiting diabetic complications |
| 06/04/2003 | EP1119256B1 Oral combination of lufenuron and nitenpyram against fleas |
| 06/04/2003 | EP1107751B1 Medicament containing platinum complex compounds and the use thereof |
| 06/04/2003 | EP1105390B1 Imidazo[1,2-a]pyridine derivatives for the treatment of gastrointestinal diseases |
| 06/04/2003 | EP1095007B1 Water-soluble zinc pyruvates or their hydrates, method for the production thereof and their use |
| 06/04/2003 | EP1089748B1 Water-soluble native dry ginkgo biloba extract with a high terpenoid and flavone glycoside content |
| 06/04/2003 | EP1075476B1 Novel benzimidazoles and benzoxazoles |
| 06/04/2003 | EP1051413B1 Quinoline derivatives as antibacterials |
| 06/04/2003 | EP1049666B1 Novel naphthyl-substituted and anilide-substituted sulfonamides |
| 06/04/2003 | EP1038863B1 Substituted dimeric compounds, process for their preparation and pharmaceutical compositions thereof |
| 06/04/2003 | EP1028721B1 N,n'-bis(sulfonyl)hydrazines useful as antineoplastic agents |
| 06/04/2003 | EP1027363B1 Adenosine a1-receptor agonists |
| 06/04/2003 | EP1017395A4 Method for treating premenstrual or late luteal phase syndrome |
| 06/04/2003 | EP1007031B1 4-cyano-4-deformylsordarin derivatives |
| 06/04/2003 | EP0994111B1 Tetrahydrofuran derivatives |
| 06/04/2003 | EP0980244B1 Use of quinazoline compounds for the treatment of polycystic kidney disease |
| 06/04/2003 | EP0977557B1 Pellet-type formulation intended for treating the intestinal tract |
| 06/04/2003 | EP0975648B1 Morphine derivatives |
| 06/04/2003 | EP0973790B1 Estra-5(10),7-dienes with estrogenic activity |
| 06/04/2003 | EP0970084B1 Pyrrolo 2,3d]pyrimidines and their use as tyrosine kinase inhibitors |
| 06/04/2003 | EP0969821B1 Pellets having a core coated with an antifungal and a polymer |
| 06/04/2003 | EP0968208B1 Quinoline and quinazoline compounds useful in therapy, particularly in the treatment of benign prostatic hyperplasia |
| 06/04/2003 | EP0968180B1 Substituted derivatives of benzosulphonamides as inhibitors of the enzyme cyclooxygenase ii |
| 06/04/2003 | EP0967210B1 Process for preparing biologically active derivatives of 1,2,4-triazol and intermediaries useful in this process |
| 06/04/2003 | EP0966439B1 Certain cyclic thio substituted acylaminoacid amide derivatives |
| 06/04/2003 | EP0964849B1 Sulfonyl urea derivatives and their use in the control of interleukin-1 activity |
| 06/04/2003 | EP0944616B1 Bicyclic aryl carboxamides and their therapeutic use |
| 06/04/2003 | EP0927031B1 Pharmaceutical preparation containing nimesulide for oral administration |
| 06/04/2003 | EP0920869B1 Stable external preparations containing acetylsalicylic acid |
| 06/04/2003 | EP0919233B1 Therapeutic agent for kidney diseases |
| 06/04/2003 | EP0910357B1 Down-regulation of dna repair to enhance sensitivity to p53-mediated suppression |
| 06/04/2003 | EP0906272B1 Peptides |
| 06/04/2003 | EP0901487B1 2,3,6 trisubstituted-4(3h)-quinazolinones |
| 06/04/2003 | EP0885010B1 Intercellular adhesion molecule powder formulation |
| 06/04/2003 | EP0882023B1 Histamine h 3 receptor ligands |
| 06/04/2003 | EP0863875B1 New 4-(oxyalkoxyphenyl)-3-oxy-piperidines for treating heart and kidney insufficiency |
| 06/04/2003 | EP0859838B1 Novel procollagens |
| 06/04/2003 | EP0858329B1 Novel stable liquid paracetamol compositions, and method for preparing same |
| 06/04/2003 | EP0858324B1 Process for aqueous granulation of clarithromycin |
| 06/04/2003 | EP0820452B1 Carbonyl-piperazinyl and piperidinil compounds which inhibit farnesyl protein transferase |
| 06/04/2003 | EP0819120B1 Tricyclic compounds useful for inhibition of farnesyl protein transferase |
| 06/04/2003 | EP0817641B1 Substances extracted from dictyotales, preparation method therefor, and compositions containing same |
| 06/04/2003 | EP0814839B1 Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a nsaid |
| 06/04/2003 | EP0789578B1 Multicatalytic protease inhibitors |
| 06/04/2003 | EP0783507B1 Compounds useful as antiproliferative agents and garft inhibitors |
| 06/04/2003 | EP0782450B1 Use of aromatase inhibitors in the preparation of a drug for treating a relative androgen deficiency in men |
| 06/04/2003 | EP0775135B1 N-substituted 3-azabicyclo (3.2.0)heptane derivatives useful as neuroleptics |
| 06/04/2003 | EP0775120B1 Novel pyrimidine derivatives and processes for the preparation thereof |
| 06/04/2003 | EP0775118B1 Benzimidazole derivatives having dopaminergic activity |
| 06/04/2003 | EP0773940B1 Process for synthesis of substituted sulphoxides |
| 06/04/2003 | EP0759437B1 Processes for the production of 2-isocephem derivatives |
| 06/04/2003 | EP0689438B1 Pharmaceutical compositions for intranasal administration of apomorphine |
| 06/04/2003 | EP0679189B1 Cloning of enterokinase and method of use |
| 06/04/2003 | EP0669809B1 Process for the heterotrophic production of microbial products with high concentrations of omega-3 highly unsaturated fatty acids |
| 06/04/2003 | EP0665752B1 Pharmaceutical compositions containing 3-beta-hydroxylated natural steroid derivatives, and use thereof |
| 06/04/2003 | EP0656037B1 Metal-mediated cross-coupling with ring-metalated porphyrins |
| 06/04/2003 | EP0656007B1 Delta opioid receptor genes |
| 06/04/2003 | EP0626848B1 The use of 4-aminopyridine in the treatment of pain and spasticity resulting from spinal cord injury |
| 06/04/2003 | EP0606366B1 Substituted phenserines and phenylcarbamates of (-)-eseroline, (-)-n1-noreseroline, and (-)-n1-benzylnoreseroline; as specific inhibitors of acetylcholinesterase |
| 06/04/2003 | CN1422283A Glycosaminoglycans derived from the K5 polysaccharide having high anticoagulant and antithrombotic activity and process for their preparation |
| 06/04/2003 | CN1422274A Alkylated imidazopyridine derivatives |
| 06/04/2003 | CN1422273A 1,5-disubstituted-3,4-dihydro-1H-pyrimido [4,5-D] pyrimidi-2-one compounds and their use in treating CSBP/P38 kinase mediated diseases |
| 06/04/2003 | CN1422272A Pyrrolopyridazine compound |
| 06/04/2003 | CN1422271A Pyrrolopyrimidinone derivatives, process of preparation and use |